HairMax LaserComb Multicentre Clinical Trials, by Clinical Drug Investigation Journal, May 2009

HAIRMAX LASERCOMB CLINICAL TRIALS FOR KEY CLINICAL STUDY IN MALES LEADING FIRST0 FDA CLEARANCE

Matt Leavitt, Glenn Charles, Eugene Heyman, David Michaels, of various sources

TrichoScience software used in multicentered, double-blind and randomized control device clinical trials for HairMax LaserComb treatment efficacy in men with Androgenetic Alopecia by evaluating hair density, mass, anagen/telogen ratio, terminal/vellus ratios and scalp condition.

Evaluation and Clinical Efficacy section, Image Analysis and Management subsection, page 287.

Originally published in Clinical Drug Investigation Journal, May 2009, by Walters Kluwer Health Company, Philadelphia, Pennsylvania, United States